Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

Along with VX-880, it is also working on encapsulated islet cells as a treatment for T1D, although that programme remains in preclinical development. Encapsulation could mean doing away with the ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

A novel study has unveiled a technique that enhances stem cell therapy for neurodegenerative diseases by combining magnetic ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.

The landscape of lupus treatment is rapidly evolving, bringing promising options such as CAR cell therapy and T-cell engager therapies. However, many individuals living with lupus, their caregivers, ...

Select adults with ischemic heart failure with reduced ejection fraction may derive benefit from an investigational cell therapy. A new trial will commence for patients with HFrEF and elevated NT ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

PHILADELPHIA – A next-generation “armored” CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer ...